Spironolactone for HIV-infected adults
Treatments studied
Part of Injuries & trauma clinical trials.
This study tests the drug spironolactone, a medicine that helps your body balance fluids and potassium, in both HIV-positive and HIV-negative adults. The goal is to see how it affects a key protein complex in your cells. If you are HIV-positive, you need to have well-controlled HIV with undetectable virus levels and be on stable treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You can give written permission to be in the study.
- If you have HIV, you must have a confirmed HIV diagnosis, be on a stable antiretroviral therapy, and have an undetectable HIV viral load.
- If you do not have HIV, you must have a negative HIV test at screening.
- You must not be pregnant, breastfeeding, or plan to become pregnant during the study.
- You must not be allergic to spironolactone or have serious kidney, liver, or heart problems.
- You must not be taking aspirin, NSAIDs (like ibuprofen), steroids, or any potassium-raising supplements/medications on a regular basis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if alendronate, a bone-strengthening medicine, can shrink the reservoir of HIV that stays in your body even when on treatment. You must have well-controlled HIV on antiretroviral therapy for at least one year but no more than ten years, and meet specific health requirements.
This trial tests whether spironolactone can help treat anemia in children aged 6-18 who are on hemodialysis. It may improve their response to current anemia treatments.
This Phase 1 study tests whether spironolactone (a medicine that affects salt and hormone balance) is safe and potentially helpful in people with alcohol use disorder. You may be eligible if you are currently drinking heavily, have low alcohol withdrawal symptoms, and meet several lab and medication safety rules.
This trial studies whether spironolactone can improve pulmonary arterial hypertension, a disease that makes the blood vessels in the lungs work too hard. You may be eligible if your condition is confirmed by specific heart-lung pressure tests and your medication plan has been stable for at least 4 weeks.
This trial tests whether spironolactone can reduce symptoms and inflammation in people with rheumatoid arthritis that is still active despite standard arthritis medicines. You may be able to join if your rheumatoid arthritis remains active and your current treatment plan has been stable for at least several months.
This study tests whether the drug spironolactone can help keep your heart in a normal rhythm after episodes of atrial fibrillation. It's for people with high blood pressure and a type of atrial fibrillation that comes and goes.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.